← All stocks

Verrica Pharmaceuticals Inc.

VRCA Net buying
CIK 0001660334 #4436 in the set updated 17 Sep 2026
Bought (120 mo)
$80.77M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.20M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$8.20M
218 of 218 sales
Net
+$72.56M
+$72.56M against sales at will

By person

18 insiders · 302 transactions
3.4×

Jayson Rieger holds only 3.4 times base salary in stock. $1.02M of shares against $300.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Jayson Rieger last reported holding, valued at $4.93, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Manning Paul B
Director
$48.04M (36)
+$48.04M
7,563,195
$37.29M
PERCEPTIVE ADVISORS LLC entity
10% owner
$30.50M (11)
+$30.50M
10,509,594
$51.81M
+191.1%
Davidson Matt
10% owner
$5.99M (185)
−$5.99M
2,556,179
$12.60M
−17.6%
Stalfort John A III
Director
$796.85K (6)
+$796.85K
1,873,800
$9.24M
+6,753%
Bonaccorso Joe
CHIEF COMMERCIAL OFFICER
$15.00K (1)
$549.90K (7)
−$534.90K
73,114
$360.45K
Rieger Jayson
CEO and President
$525.86K (4)
+$525.86K
207,593
$1.02M
Hayes Christopher G.
CHIEF LEGAL OFFICER
$61.97K (3)
$511.77K (8)
−$449.80K
176,458
$869.94K
+135.3%
White Ted
PRESIDENT AND CEO
$268.47K (7)
$662.91K (7)
−$394.44K
215,967
$1.06M
Goldenberg Gary
Chief Medical Officer
$50.00K (1)
$330.49K (7)
−$280.49K
94,261
$464.71K
Kohler Terry
CHIEF FINANCIAL OFFICER
$160.14K (4)
−$160.14K
44,697
$220.36K
Palczuk Linda
Chief Operating Officer
$117.89K (3)
+$117.89K
8,500
$41.91K
DAVIS A BRIAN
Chief Financial Officer
$98.75K (2)
+$98.75K
12,900
$63.60K
Ballaron Craig
Director
$88.78K (2)
+$88.78K
10,000
$49.30K
Zawitz David
Chief Operating Officer
$72.31K (2)
+$72.31K
27,000
$133.11K
+145.5%
Degnan Chris
Chief Financial Officer
$45.00K (1)
+$45.00K
3,000
$14.79K
Rosenberg Noah L.
CMO
$40.61K (3)
+$40.61K
8,587
$42.33K
Kirby John J.
Interim CFO
$39.65K (2)
+$39.65K
23,962
$118.13K
OCLASSEN GLENN A
Director
65,421
$322.53K
−27.1%

No percentages here. This company's share count has moved by a factor of 9.7 over the window, from 9,445,768 to 91,779,993 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 218
Transactions with no price 4
Shares from compensation/vesting 19,337,748
Sales filed before the plan box existed 185
History held since 18 Jun 2018